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Abstract
Objective To study the efficacy of percutaneous epididymal
sperm aspiration (PESA) in combination with short time
insemination to treat infertile men with obstructive azoosper-
mia (OA).
Design Paired randomized controlled trial in which each cou-
ple’s cohort of oocytes was divided into two equal groups.
Setting Center for reproductive care.
Patients Twenty men with OA.
Interventions Motile spermatozoa were collected using
PESA. Half of the oocytes were used for intracytoplasmic
sperm injection (ICSI). The rest were inseminated briefly with
PESA sperm in vitro fertilization (IVF). After 4–5 h, the
remaining cumulus cells were removed mechanically for sec-
ond polar body observation to decide whether to apply “res-
cue” ICSI (RE-ICSI).
Main outcome measures Rates of oocyte maturation, fertili-
zation, cleavage, and good quality embryos. Numbers of
available embryos and good quality embryos were compared
between PESA-IVF (using a short incubation protocol+-
rescue ICSI) group and PESA-ICSI group.
Results In the short time insemination group, cumulus cells
were dispersed by PESA spermatozoa. No second polar bod-
ies were found, so RE-ICSI was done. PESA-IVF + RE-ICSI
and PESA-ICSI outcomes were comparable in terms of fertil-
ization rates, 2PN cleavage rate and good quality embryo rates
with no statistically significant differences.
Conclusions PESA sperm without centrifugation could dis-
perse the cumulus cells but were infertile and therefore could
substitute for synthetic hyaluronidase. The outcomes of
PESA-IVF with rescue ICSI were equivalent to PESA-ICSI.
Using spermatozoa obtained by PESA and IVF before RE-
ICIS is a viable treatment for men with OA.
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Introduction
Obstructive azoospermia (OA) is characterized by an occlu-
sion or partial absence of the male reproductive tract with the
presence of normal spermatogenesis [1]. The standard treat-
ment for infertile men with OA, whether congenital or ac-
quired, is percutaneous epididymal sperm aspiration (PESA)
followed by intracytoplasmic sperm injection (ICSI) [2, 3].
Achieving pregnancies and the birth of normal, healthy infants
using epididymal spermatozoa together with conventional
in vitro fertilization (IVF) [4–6] or intrauterine insemination
(IUI) [7–9] indicates that the epididymal sperm can fertilize
both in vitro and in vivo.
Capsule PESA sperm without centrifugation could disperse the cumulus
cells and using it and IVF beforeRE-ICIS is a viable treatment for men
with OA.
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In 1985, Temple-Smith [4] reported the first pregnancy
with the use of spermatozoa obtained by microsurgical
epididymal sperm aspiration (MESA) and IVF. In 1988,
proximal (caput) epididymal sperm were demonstrated to
have better motility than senescent sperm in the distal
(cauda) epididymis, and it was thought that retrieval of
motile sperm from the caput would yield reliable fertili-
zation and pregnancy rates after conventional IVF [5]. As
an alternative to MESA, a simplified method, PESA was
introduced for retrieval of epididymal spermatozoa in
patients with OA [10, 11]. However, the numbers of
aspirated epididymal spermatozoa are generally low after
MESA/PESA compared with ejaculated spermatozoa. The
fertilization rate using MESA/PESA in combination with
conventional IVF has been low [12], but since the intro-
duction of ICSI [13], fertilization rates with the use of
epididymal spermatozoa after PESA have improved [14].
We have used short time insemination for couples with
primary infertility, with unexplained infertility, or where
the male partner has mild oligozoospermia or astheno-
zoospermia to avoid low fertilization rates or complete
fertilization failure [15, 16]. The cumulus cells were par-
tially dispersed by the spermatozoa instead of by conven-
tional hyaluronidase treatment at 6 h of insemination for
observing oocyte maturation and second polar body ex-
trusion [16]. Oocytes were subjected to early rescue ICSI
(RE-ICSI) if there was fertilization failure or a low fertil-
ization rate [16, 17]. PESA in combination with conven-
tional IVF gives low fertilization rates. Therefore, we
chose those patients with OA and adequate sperm motility




From March 2012 to May 2013, infertile patients at Shijia-
zhuang No. 4 Hospital were evaluated. Men with an
azoospermic ejaculate, with absent or low fructose associated
with nonpalpable vasa deferentia were diagnosed with OA.
Clinical histories, physical examinations, and measures of
serum hormone levels were obtained preoperatively. Labora-
tory endocrinology assays for serum follicle-stimulating hor-
mone (FSH) and testosterone levels were within the normal
range. The combination of short time insemination and sperm
retrieval was offered to couples with male factor infertility
caused by bilateral OA. The protocol and potential risks and
benefits of the study were explained to participants before
they provided written informed consent. Institutional ethics
committee approval was obtained, all subjects were informed
of the study and written informed consent was obtained from
each subject prior to the performance of any study procedures.
PESA
For PESA, a 26-gauge needle attached to a 1-mL tuberculin
syringe was inserted through the scrotal skin into the epidid-
ymis. Negative pressure was created by pulling the syringe
plunger while the tip of the needle was moved gently in and
out of the epididymal duct until a clear fluid was seen coming
into the syringe. The aspirate was flushed into a tube contain-
ing warm sperm medium (US ART products) and taken to the
laboratory for immediate microscopic examination [1]. It has
been recommended to commence aspiration at the caput and
corpus of the epididymis because aspirates from the cauda
usually contain poor quality senescent spermatozoa, debris
and macrophages [18, 19]. The epididymal aspirates were
diluted in 1 ml IVF medium at room temperature. Good
quality motile spermatozoa found in PESA aspirates were
included, so we did not centrifuge them. Aspirates with lots
of debris, macrophages or red blood cells were excluded.
ICSI and short time insemination plus RE-ICSI
We applied this protocol whenever the required quantity of
motile sperm was collected by PESA and more than 10
oocytes were collected. The sibling oocytes were randomized
into two groups. Half of the oocytes used for ICSI were treated
with bovine hyaluronidase (Sigma-Aldrich, St Louis, MO,
USA) for dispersing the cumulus cells 5 h after oocyte collec-
tion followed by ICSI, which was performed according to
Esteves et al. [2, 3]. The remaining oocytes were mixed with
PESA sperm for short time insemination 2–2.5 h after
collecting the oocytes and the cumulus cells were removed
mechanically after 4–5 h co-incubation for polar body obser-
vation to decide whether to perform RE-ICSI [17].
Embryos were cultured in Quinn’s sequential culture me-
dium (US ART products) with 5.5 % CO2 at 37 °C. The ICSI
fertilization rate was defined as the number of fertilized oo-
cytes based on the numbers of pronuclei (PN) and completion
of meiosis II (MII) as (number of 1PN+2PN+more PN+late
cleavage zygotes)/number of MII oocytes. The number of
“available” embryos was defined as the number of embryos
transferred on day 3 of culture plus all cryopreserved embryos.
“Good quality embryos” should have 7–8 cells on day 3,
contain less than 20 % fragments, but might be a little uneven
in appearance. The “good quality embryo rate”was defined as
the number of quality embryos divided by the number of
available embryos [20]. Rates of oocyte maturation, fertiliza-
tion, cleavage, and good quality embryos, and numbers of
available embryos and good quality embryos were compared
between the groups.
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Data analysis
Analyses were performed using the SPSS 13.0 statistical
software package (SPSS Inc., Chicago, IL, USA). The
results are presented as the mean values (± SD). Differ-
ences between the groups were analyzed using Student’s t
or χ2 tests and P<0.05 was considered statistically
significant.
Results
The patients’ mean age was 25.6±5.3 years, the female
partners ranged in age from 22 to 32 years with a mean
duration of primary infertility of 4.1±4.7 years. Twenty
couples were included with a total of 282 oocytes and 141
oocytes in each treatment group. The cumulus cells had
been dispersed by the PESA spermatozoa and were easy
to remove after 4 h in the IVF short time insemination
group. No oocytes with a second polar body were found
so these oocytes were subjected to RE-ICSI. Therefore,
we regarded the short time insemination group as the RE-
ICSI group. Comparing the two groups, the numbers of
MII oocytes, ICSI and RE-ICSI fertilization rates, cleav-
age rates and numbers of available embryos were similar.
There were more good quality embryos and higher good
quality embryo rate in the RE-ICSI group than in the ICSI
group, but the results had no statistical significance
(Table 1).
PESA sperm without centrifugation could disperse the
cumulus cells but were infertile and therefore could be
used as a substitute for synthetic hyaluronidase. The out-
comes of PESA-IVF with rescue ICSI is equivalent to
PESA-ICSI. Thus spermatozoa obtained by PESA plus
short time insemination and RE-ICSI is a valid treatment
for men with OA.
Discussion
Causes of OA are classified into two groups; acquired and
congenital. Acquired OA include vasectomy, failure of vasec-
tomy reversal, post-infectious disease, surgical procedures in
the scrotal, inguinal, pelvic or abdominal regions, and trauma
[2, 21]. Congenital causes of OA include cystic fibrosis,
congenital absence of the vas deferens (CAVD), ejaculatory
duct or prostatic cysts, and Young’s syndrome [3, 21].
Treatment of patients with OA is usually using PESA to get
enough sperm to perform ICSI. Hirsh [18] reported that ade-
quate sperm preparations were obtained in 46/50 treatment
cycles (92 %) of patients with OAwith the best motility found
in the caput epididymis in 89 % of cases. In another study, the
PESA sperm count was adequate (≥20 × 106/ml) in 13.8 % of
cases and 20 % sperm motility was obtained in 15.5 % of
sperm retrievals [19]. Here, aspirates with lots of debris,
macrophages or red blood cells were excluded; only good
quality motile spermatozoa were included, so we did not
centrifuge them.
Spermatozoa approaching the oocyte have to overcome
three main obstacles: the cumulus-corona complex, the zona
pellucida and the oolemma. The cumulus-corona complex is
composed of granulose-derived cumulus cells embedded in a
matrix of hyaluronan oligosaccharide chains cross-linked by
hyaluronan binding proteins and proteoglycans, and sur-
rounds each oocyte [22]. In IVF, acrosomal enzymes of the
inseminated spermatozoa can disperse the cumulus cells and
most of the spermatozoa have the ability of fertilization.
Oocyte activation is judged by the presence of two polar
bodies following cumulus cell removal at 4 h after insemina-
tion [23]. The mean epididymal sperm fertilization rate was
only 11.2–19 % using conventional IVF [12]. Those fertiliza-
tion failures after conventional IVF appeared to be because of
the inability of spermatozoa to penetrate the zona pellucida
rather than to an inability to reach the zona [24]. Therefore,
PESA-derived spermatozoa can disperse the cumulus cells
instead of hyaluronidase, so we can use them for PESA-IVF
(using a short incubation protocol+rescue ICSI). Epididymal
sperm possess fertilization capacity after centrifugation not
only in vivo [6–9] but also in vitro [4, 5]. However, the results
of this study demonstrate that epididymal sperm have no
fertilization ability without centrifugation. The reason is un-
known; perhaps centrifugation may have a “washing” effect
that helps to remove any coating “decapacitation factors” that
activate the spermatozoa for penetrating the zona pellucida.
Because of the low fertilization rate of PESA-IVF, low
pregnancy rate of PESA-IUI, and the implementation of ICSI
technology, almost all OA patients were treated with ICSI
directly. Recently, RE-ICSI has become a reasonable method
for patients with total fertilization failure (TFF) or low fertil-
ization rate [23]. Hence, we considered trialing a combination
of PESA-IVF and RE-ICSI a viable treatment for OA. Since
Table 1 Comparison of two groups of twenty OA patients
ICSI group RE-ICSI group P
Oocytes 141 141
MII oocyte rate (%) 85.8(121/141) 87.2(123/141) 0.728
Fertilization rate (%) 85.1(103/121) 87.0(107/123) 0.674
1PN rate (%) 2.5(3/121) 2.4(3/123) 0.948
2PN rate (%) 76.0(92/121) 78.0(96/123) 0.709
>2PN rate (%) 3.3(4/121) 3.2(4/123) 0.918
Late cleavage rate (%) 3.3(4/121) 3.2(4/123) 0.918
2PN cleavage rate (%) 97.8(90/92) 96.9(93/96) 0.686
Available embryos 85 87
Good quality embryos 42 46
Good quality embryo rate (%) 49.4(42/85) 52.9(46/87) 0.651
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ICSI was first developed, bovine or ovine hyaluronidase has
been used routinely for oocyte denudation [25]. This enzyme
digests the hyaluronic acid interspaced between the cumulus
cells [26], thus liberating the oocyte for maturity grading and
microinjection. To reduce unknown harmful effects from the
enzyme, hyaluronidase preparation, low enzyme concentra-
tions and short time incubation of the cumulus–oocyte com-
plexes are recommended [25]. Animal-derived products have
limited purity and accidental transmission of pathogens can-
not be excluded fully. These limitations inevitably imply an
increased need for mechanical dispersal of the cumulus and
corona by means of multiple pipetting, which could be harm-
ful to the oocyte [27]. Evison and De Vos reported that the use
of human recombinant hyaluronidase could improve ICSI
survival and good embryo development compared with bo-
vine hyaluronidase [27, 28].
There were twomain differences between the ICSI and RE-
ICSI groups: (1) the cumulus cells were dispersed by PESA-
derived spermatozoa in RE-ICSI group, reducing the potential
harmful effects of hyaluronidase in the ICSI group; and (2) the
timing of microinjection. Microinjection time for the ICSI
group was about 1 h earlier than that of the RE-ICSI group.
Traditional RE-ICSI is done slightly later (6 h after short
insemination) to prevent a delay in second polar body extru-
sion. Here, the >2PN fertilization rate was similar in the two
groups and indicates that PESA sperm without centrifugation
have no fertilization ability. Therefore, it was feasible to
conduct RE-ICSI a little earlier (4 h after short insemination).
RE-ICSI performed earlier could result in better outcomes in
the select group of patients [29] and it has been shown that the
good quality embryo rate of a RE-ICSI group can be higher
than that in an ICSI group when using ejaculated spermatozoa
[30]. Previous studies showed that epididymal sperm from
patients with OA and with a longer epididymis have a higher
IVF rate than from those with a shorter epididymis [31, 32].
However, there was no difference between these types of men
when doing ICSI [33].
Unique features of our study include using motility sper-
matozoa acquired from PESAwithout centrifugation, a short
period insemination to disperse the cumulus cells and simulate
physiological conditions, and RE-ICSI performed as early as
possible when no second polar body was found. The limita-
tions of this study are that the number of cases was too few to
reach any significant conclusions and the data require valida-
tion with later clinical outcomes (e.g. clinical pregnancy
rates).
Compared with PESA-ICSI, the procedure of PESA-IVF
plus RE-ICSI can disperse the cumulus cells but needs enough
motile sperm. The outcomes of sibling oocytes separated into
two groups are equivalent. The PESA-IVF plus RE-ICSI
procedure is more “complicated” than using ICSI directly
but can offer a feasible method for the treatment of men with
OA.
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